Koyfin Home > Directory > Health Care > Adamas Pharma > Total Debt / EBITDA

Adamas Pharma Total Debt / EBITDA Chart (ADMS)

Adamas Pharma annual/quarterly Total Debt / EBITDA from 2012 to 2020.
  • Adamas Pharma Total Debt / EBITDA for the quarter ending June 06, 2020 was $-5m a 66.88% decrease of -4m year over year
  • Adamas Pharma Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $-2m a 35.61% decrease of -1m year over year
  • Adamas Pharma Annual Total Debt / EBITDA for 2019 was $-2m a 33.89% decrease of -1m from 2018
  • Adamas Pharma Annual Total Debt / EBITDA for 2018 was $-1m a -12.78% increase of 0m from 2017
  • Adamas Pharma Annual Total Debt / EBITDA for 2017 was $-1m a 116.91% decrease of -1m from 2016
Other Ratios Metrics:
  • Adamas Pharma Total Debt / Capital for the quarter ending September 09, 2018 was $50m a -21.13% decrease of -11m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
  • Adamas Pharma Total Debt / Equity for the quarter ending September 09, 2018 was $101m a -53.94% decrease of -54m year over year
View Chart On Koyfin

Quarterly ADMS Total Debt / EBITDA Data

06/2020$-5m
03/2020$-3m
12/2019$-2m
09/2019$-2m
06/2019$-2m
03/2019$-1m
12/2018$-1m
09/2018$-1m
06/2018$-1m
03/2018$-1m

Annual ADMS Total Debt / EBITDA Data

2019$-2m
2018$-1m
2017$-1m
2012$0m